Many flavonoids may prevent or improve tumorigenic outcomes by reducing AHR and/or CYP1A1/CYP1B1 activity, or by preventing PAH-induced genotoxicity [30]. Here, CYP1A1 is linked to pulmonary arterial hypertension.